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This survey is based on the following publications, which are referred 
to in the text by Roman numerals as fo llows: 
I. Immunodiffusion analysis of human, monkey and rabbit acute phase 
proteins. 
Int. Arch. Allergy 32:545—562, 1967. 
II. Qualitative analysis of acute phase protein antisera with the com­
parative interference diffusion-in-gel technique. 
Int. Arch. Allergy 33:16—28, 1968. 
III. Comparative testing of precipitation methods for quantitation of 
C-reactive protein in blood serum. 
Acta path, microbiol. scand. In press. 
IV. C-reactive protein in a random sample of Swedish men aged fifty. 
Distribution and relation to clinical manifestations. 
Co-author: G. Tibblin. 
Acta med. scand. In press. 
V. C-reactive protein in apparently healthy individuals (blood donors) 
related to age. 
Acta path, microbiol. scand. In press. 
Nomenclature 
Acute phase protein without indication of species is used as the designa­
tion of the C-reactive protein equivalents in man, monkey and rabbit. Acute 
phase serum is used as a designation of blood serum containing acute phase 
protein. C-reactive protein (CRP) and Cx-reactive protein (CxRP) are 
used as designations of acute phase protein from man and rabbit respec­
tively. Unless otherwise indicated, the designation CRP refers to the 
human acute phase protein. 
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Introduction 
C-l'eactive protein (CRP) is one of a number of plasma constituents 
which have been designated as acute phase reactants (91). CRP seems to be 
unique among these in that it has generally been reported not to be de­
monstrable in healthy subjects (15, 27). CRP was detected in 1930 by 
Tillett & Francis (100) as a serum "precipitin" which reacted with "frac­
tion C", a polysaccharide which could be extracted from R as well as S 
strains of pneumococci (101). Tillett and Francis found the "precipitins" 
in the sera from patients acutely ill with lobar pneumonia but not 1—3 
days after the crisis. Furthermore, sera from patients suffering from 
diseases o ther than pneumonia, such as streptococcal and staphylococcal 
infections and rheumatic pericarditis, showed this special type of reactivity. 
Some years later Ash (9) in an extended study demonstrated "precipitins" 
against "fraction C" in serum during the acute stages of additional in­
fectious diseases caused by gram-positive as well as gram-negative bacteria. 
Furthermore, she pointed out the relationship between fever and increased 
sedimentation rate on the one hand and the presence of C-precipitating 
substance on the other. 
In a series of papers from the Rockefeller Institute (3, 62, 63, 66, 111) 
some of the physico-chemical and immunological properties of the substance 
were elucidated. Its protein nature was suggested by Abernethy & Avery 
(3) in 1941 and the designation, C-reactive protein, was applied (63). Due 
to its presence during the active stage of a disease it has also been called 
acute phase protein (37, 82). The C-polysaccharide — CRP reaction is 
dependent on the presence of calcium ions (3). Recent investigations by 
Gotschlich & Liu (30) have indicated that the major CRP-reacting part 
of the C-polysaccharide is /"/-ac etylgalactosamine phosphate. The ^poly­
saccharide — CRP reaction was shown to be specifically inhibited by 
various phosphate monoesters of low molecular weight (29, 44). CRP 
occurs in serum associated with a lipid (62), which reacts with anti-/?-
lipoprotein (108). 
In 1937 Abernethy (2) showed that acute phase sera from monkeys, but 
not from rabbits, infected with pneumococci were precipitated by the 
C-polysaccharide. Monkey acute phase protein was shown to cross-react 
with rabbit anti-human CRP (63). The occurrence in the rabbit of an 
analogous substance was described by Anderson & McCarty (7) in 1951. 
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The rabbit protein reacted only with a specially prepared form of the 
pneumococcal C-polysaccharide, the so-called Cx-polysaccharide, and not 
with the C-polysaccharide prepared as o riginally described. On the other 
hand human CRP reacts v/ith both C- and Cx-polysaccharide. According 
to the latter authors the C-polysaccharide should be a somewhat more 
degraded form of Cx-polysaccharide (7). Due to its reactivity the protein 
found in rabbits was labelled CxRP. An immunological relationship be­
tween man, monkey and rabbit acute phase proteins was demonstrated in 
1960 by Gotschlich & Stetson (31) employing the comparative double 
diffusion-in-gel technique. 
Independently, Löfström (58, 59) in 1939 noted that under certain con­
ditions a substance occurred in blood serum which caused swelling of the 
capsules of some pneumococci, among others, of types 27 and 28. The 
substance was called "nonspecific capsular swelling substance", and, by 
cross-absorption studies, was shown to be identical with CRP (60). 
In 1941 MacLeod & Avery (62) isolated CRP from human serum and 
showed its antigenicity in rabbits (63). The protein was crystallized in 
1947 by McCarty (66). In the capillary tube precipitation test devised 
by Anderson & McCarty (6) antiserum against human CRP (CRPA) was 
employed for the demonstration of CRP. This technique was shown to be 
at least ten times as sen sitive as the precipitation reaction with pneumo­
coccal C-polysaccharide (109), and it is still the most commonly employed 
routine technique for demonstration of CRP. 
The clinical significance of the presence of CRP in blood serum was 
further elucidated by a large number of studies during the following years. 
The comprehensive studies of Hedlund (37) and Keitel, Diesner & Bannert 
(48) should be specially mentioned. Reviews on the subject have been 
given by Good (27) and Schwarz (93) among others. From these w orks it 
appears that the presence of CRP in blood serum can be regarded as an 
indication of an inflammatory or necrotic process i n the organism. Espe­
cially the diagnostic value of CRP in acute rheumatic fever (6, 37,110) and 
myocardial infarction (37, 53, 54) has been pointed out. It has been as­
sumed that CRP vanishes during recovery from the disease and is generally 
not demonstrable in healthy subjects. In this connection it is interest ing to 
note that Vedros & Fishel (103), separating normal sera by starch block 
electrophoresis, obtained fractions in the albumin and the y-globulin 
regions whi ch reacted with Cx-polysaccharide but not with CRPA. Their 
findings were thought to indicate that CRP was constantly present in 
serum but that its detection in normal serum might be masked through the 
presence of a substance in serum migrating with the ao-globulins in s tarch 
electrophoresis. 
CRP has been shown to be present during pregnancy (10, 34, 68 , 70, 71, 
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84, 86, 94) but does not seem to pass the placental barrier (10, 34, 70, 71, 
84, 86) or to be present in the milk (34, 59, 76). Since CRP has been 
demonstrated in very young infants it seems that the capacity to form 
CRP is present early in life (10, 34, 70, 71, 84, 86). 
The antigenic nature of CRP has been studied by Libretti, Kaplan & 
Goldin (56, 57) who employed diffusion-in-gel analysis. These authors 
demonstrated 1—3 precipitation lines when CRP-containing blood serum 
or pleural fluid was analysed by means of CRPA, whereas crystalline 
CRP always gave three lines. These results were interpreted to indicate 
the presence of three antigens in CRP. It was concluded that the concentra­
tions of these different components varied in different sera. In the later 
report (56), however, a denaturation of CRP was also considered as a 
cause of the multiple precipitation lines. Nishim ura (75), as well as Nilsson 
& Hanson (34, 74) in diffusion-in-gel analyses obtained results which could 
be interpreted as confirmation of a serological heterogeneity of CRP. 
Other authors have been unable to show more than one precipitation line 
when analysing CRP—CRPA systems with this technique (e.g. 23, 67, 81, 
85, 97). Diffusion-in-gel analyses have not revealed any antigenic dif­
ferences in CRP from different individuals with various diseases (56, 61, 
81, 97). Findings indicative of a heterogeneity of CRP have however been 
reported by Hedlund (36) and Fishel, Vedros & Rothlauf (20) in absorp­
tion experiments with pneumococci and/or pneumococcal C-polysaccha-
ride. 
The electrophoretic behaviour of CRP has been the subject of many 
controversial reports. Perlman, Bullowa & Goodkind (82) employing free 
electrophoresis, as well as Horming & Morris (45) using paper electro­
phoresis, by indirect means concluded that CRP probably migrated with 
the a-globulin fraction of serum. On the other hand the results of W ood, 
McCarty & Slater (111) as well as Hansen, Marner <5- Ejby-Poulsen (32) 
indicated that CRP moved with the /9-globulins in free electrophoresis. 
The former authors (111) s tated that it moved with the fast y-globulins at 
zone electrophoresis on starch. Hedlund & Brattsten (38) employing con­
tinuous zone electrophoresis on starch localized the CRP in the y-globulin 
fraction whereas Philipson & T veter as (84) and Gedin & Porath (24) using 
zone electrophoresis in vertical columns with a cellulose medium found 
CRP to move intermediate between ß- and /-globulins! Immunoelectro-
phoretic studies have also given somewhat conflicting results, most authors, 
however, refer the mobility of CRP in agar gel or on paper to the ß- (11, 
23, 25, 40, 67, 83) or y-region (12, 13, 61, 112, 113) or between these 
regions (1, 81, 98). Fishel (19) observed that the position of CRP in im-
munoelectrophoretic patterns produced at different pH values ranging from 
6.9 to 8.6 did not change relative to the origin whereas Davila (16) found 
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the localization of CRP to vary between the albumin and the y-globulin 
regions in conjunction with pH changes between 7.0 and 8.3. The dis­
crepant electrophoretic mobilities reported, have been explained by dif­
ferences in experimental conditions and the varying adsorption of CRP 
to the supporting media (16, 23, 25, 32, 38, 67, 84). Differences in the 
state of aggregation of CRP have also been considered (41). Indications 
of an electrophoretic heterogeneity of CRP have been reported by several 
authors (14, 39, 75, 81, 92, 96). Anzai, Sato, Fukuda & Carpenter (8) 
demonstrated three immunoelectrophoretic types of CRP, designated ß, y 
and 2H, and their findings were interpreted to indicate that CRP con­
sisted of two proteins differing in electrophoretic mobility but with identi­
cal antigenicity. Hokama, Coleman & Riley (42) ascribe these findings to 
an interaction between CRP and low levels of Lewis and/or H blood 
group substances in serum. 
According to Gotschlich & Edelman (28) the CRP molecule probably 
consists of subunits with a molecular weight of 21,500. These authors 
proposed two possible models for the CRP, each consisting of six subunits. 
The six-subunit model should probably represent only one of several forms 
since the molecular weight of CRP was found to range between 110,000 
and 144,000 by utracentrifugal analysis. 
The aim of the author's investigation 
The capillary tube precipitation test for demonstration of CRP has been 
considered satisfactory for clinical routine work. However, for more 
detailed analysis of the properties and occurrence of CRP, a more sensitive 
and accurate test for determination of CRP was considered necessary. 
Since diffusion-in-gel techniques have proved to be of value for qualitative 
and quantitative immunological analyses, some of these were applied to 
study of CRP with the following main purposes. 
1. To study the immunodiffusion characteristics including the antigen 
mosaics of ac ute phase proteins from man, monkey and rabbit. 
2. To evaluate some immunological techniques for determination of 
CRP. 
3. To examine quantitatively the CRP in some populations and to 
analyse these results in relation to certain clinical and laboratory 
variables, as well as the age, of the individuals. 
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Materials 
Native acute phase protein antigens (I, II) 
In order to minimize denaturation of the antigens, studies of the antigen 
mosaics of acute phase proteins were performed with freshly drawn samples 
which were used either within 24 h after sampling or after storage at 
—20° C. Ascites fro m a woman suffering from a metastasizing cancer of 
the caecum was used as the human CRP reference antigen. Acute phase 
sera were obtained from monkeys and rabbits injected 24 h earlier with 
typhoid-paratyphoid vaccine or live virulent pneumococci, t ype 27. 
Purified acute phase protein antigens (I, III) 
Purified human CRP was used for production of antisera in animals (I) 
and for standardization of the quantitative determination technique (III). 
The method of Wood et al. (Ill) employing precipitation with C-poly-
saccharide was used for preparation of CRP (I). A modification of the 
chromatographic technique elaborated by Hokama & Riley (43) was also 
employed (I, III). After preparation of "crude CRP" according to the 
latter authors, purification was pursued by subsequent gel filtration on 
Sephadex G-200. This procedure gave a material which presumably was 
immunologically pure, since immunization with a total amount of 1.4 mg 
CRP emulsified in Freund's adjuvant for a period of 4 months did not 
stimulate rabbits to formation of antibodies other than those to CRP as 
tested by the diffusion-in-gel technique (III). The diffusion coefficient in 
agar gel of this purified CRP was measured with the angle plate technique 
of Allison & Humphrey (5) based on a principle given by Ouchterlony 
(77). It was not found to deviate significantly from that of native human 
CRP (III). 
Acute phase protein from monkey was also purified with the chromato­
graphic method of Hokama & Riley (43) (I). Since the monkey acute phase 
protein was used only for immunization purposes a purity as h igh as t hat 
of the human CRP was considered unnecessary, and further purification 
by gel filtration was therefore not performed. In contrast to the human 
and monkey proteins, rabbit acute phase protein was not retained by the 
DEAE-cellulose with the buffer system used (0.05 M sodium citrate buffer, 
pH 7.0, containing 0.1 M NaCl) (73). 
Human blood sera 
For the methodological and population studies blood sera from the fol­
lowing populations were used: 
50-year-old men (III, group A; IV). These men were randomly selected 
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from the register of the Revenue Office of Göteborg and comprised a ll the 
men living in Göteborg in 1963, born in 1913 on dates which are multiples 
of three. Nine hundred and seventy-three men were originally selected, 855 
(88 °/o) of whom were clinically examined in the hospital. The clinical 
part of the study as w ell as a n analysis of the nonparticipating group has 
been described by Tibblin (99). At the time when the CRP analyses were 
performed, 835 of the 855 sera were available for study. Quantitative 
immunodiffusion analyses for CRP were performed on 826 of these sera. 
All sera were stored at —20° C until used for analysis. 
Blood donors (V). Blood sera were obtained from the Blood Bank of the 
Sahlgren Hospital, Göteborg, from 405 blood donors of different ages. 
Physical examination of the donors was not performed, but anamnestic 
inquiries were made regarding certain diseases such as syphilis, malaria, 
tuberculosis, hepatitis, asthma or other allergic disorders. Donors who have 
had these diseases are not admitted. The donors are also requested to state 
diseases occurring since the preceding donation. The sedimentation rate 
exceeded 16 mm/h in only 7 of the 395 donors in whom it was determined. 
These 7 cases were not confined to any special age group. 
Patients (III, group B). One hundred and thirty-five samples were 
selected from the sera sent to the Bacteriological Laboratory of the Sahl­
gren Hospital, Göteborg, for CRP determination. Only sera found CRP 
positive with the capillary tube precipitation technique (6) were included 
in this series. 
Antisera to acute phase proteins 
Antisera against human CRP (CRPA) were produced in a goat (I), a 
monkey (I) and rabbits (III) by injection with purified CRP (I, III). 
The antisera obtained from goat were absorbed with a CRP negative 
serum to remove precipitating antibodies other than those against CRP. 
Commercial CRPA antisera""), fr om rabbit as well as pooled from sheep 
and goat, were also employed. Antiserum against monkey CRP was pro­
duced in a hen by injection of purified monkey CRP. Antibodies against 
monkey serum proteins other than acute phase protein were removed by 
absorption with a CRP negative monkey serum. An antiserum against 
rabbit CxRP produced in goat*) was employed after absorption with 
normal rabbit serum. Portions of each of the three acute phase protein 
antisera were absorbed with the two heterologous native acute phase 
protein antigens. The adequacy of the absorption of the antisera was tested 
by means of the diffusion-in-gel technique with the absorbing antigen. 
*) Hyland Laboratories, Los Angeles, Calif., USA 
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Immunological methods 
The comparative double diffusion-in-gel method of Ouchterlony (77) 
was used in the modifications of Hanson (33) and Wadsworth (105). The 
elaborated interference diffusion-in-gel technique was used as described in 
II. Regular and comparative immunoelectrophoretic analyses were per­
formed as described by Wadsworth & Hanson (106). The capillary tube 
precipitation technique fo r demonstration of CRP was that described by 
Anderson & McCarty (6) (III). The single radial immunodiffusion (halo) 
technique according to Mancini, Carbonara & Heremans (64) was per­
formed as describe d in III. 
The antigen mosaics of acute phase proteins (I, II) 
The antigen mosaics were studied with the comparative double diffusion-
in-gel technique (77). Interpretation of precipitation patterns obtained 
with this technique has been discu ssed by several authors (e.g. 51, 79, 80) 
and has withstood experimental trial at least in regard to comparative 
analysis of antigens. The patterns obtained in the present st udy (I) were 
type reactions I (reaction of fusion), III (reaction of partial fusion) a nd 
IV (reaction of inhibition), and they were interpreted according to 
Ouchterlony (79). 
"When each of the acute phase proteins fr om the three speci es was ana­
lysed with its corresponding homologous or heterologous antisera with 
the double diffusion-in-gel method one precipitation line was obtained. 
Results obtained when human CRP was analysed with the monkey anti-
human CRP were considered especially indicative of an immunological 
homogeneity of the human acute phase protein. This was not in accord 
with the results of Libretti et al. (57) as well as others (20, 75, 92). Some 
of the author's previous studies were also tho ught to indicate an immuno­
logical heterogeneity of CRP since some CRP—CRPA systems gave two 
precipitation lines (34, 74). A crossing of these lines was obtained in some 
instances. These findings were later re-evaluated (I) and it was suggeste d 
that these early results were probably due t o denaturation of CRP in the 
analysed sera o r possibly t o imbalance of the systems tested. By means of 
the comparative diffusion-in-gel technique i t was shown that splitting of 
native CRP into serologically reactive fragmen ts might occur after some 
months of storage at +4° C (I). 
Neither did immunoelectrophoretic analyses give evidence of an immu-
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Fig. 1 a and b. Regular and comparative immunoelectrophoretic analyses of human 
CRP-containing sera (circular start basins) by means of CRPA (clear longitudinal basins) 
and the human CRP reference antigen (opaque longitudinal basins), a) Serum with a 
high CRPconcentration. b) S erum with a low CRP concentration. 
Fig. 1 c. Comparative immunoelectrophoretic analysis of a purified human CRP prepa­
ration before gel filtration (circular start basin) by means of sheep anti-human serum 
(see I) (upper longitudinal basin) and a CRP negative human serum (lower longitudinal 
basin). 
nological heterogeneity of acute phase protein. However, an electro-
phoretic heterogeneity of acute phase protein was demonstrated in each 
of the three species ana lysed; this was especially evident when the com­
parative immunoelectrophoretic technique was employed. The results ob­
tained with a partly purified human CRP preparation indicated at least 
four groups of particles with different electrophoretic mobilities but with 
indistinguishable antigen composition (I) (Fig. 1). The patterns obtained in 
analyses of the purified human CRP preparation as well as the native acute 
phase protein antigens were not in accord with a continuous spectrum 
of d ifferently charged particles as suggested by Schnitze & Heremans (90). 
Comparative testing was performed on acute phase proteins from man, 
monkey and rabbit by means of unabsorbed and absorbed homologous anti-
sera in order to integrate the antigenic factors revealed. The precipitation 
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TABLE 1 
Antigen mosaics of acute phase proteins f rom man, 
monkey and rabbit 
Species 
Antigenic determinants 
a b c d e 
Man + + + - -
Monkey - + + - + 
Rabbit _ - + + -
patterns obtained were in accord with findings published by other authors 
(31, 55). The present results ind icated at least five different antigenic de­
terminants labelled a, b, c, d and e o n the three acute phase proteins (I). 
These occurred in varying combinations on the proteins studied. One of 
t h e  d e t e r m i n a n t s  ( c )  w a s  c o m m o n  t o  a l l  t h r e e  a c u t e  p h a s e  p r o t e i n s ,  o n e  ( b )  
was common to the human and monkey acute phase proteins whereas the 
other three were found one in each species, the human (a), the monkey 
(e) and the rabbit (d) proteins, but could not be demonstrated in the other 
two (Table 1). Thus differences in antigen mosaic were indicated for the 
three acute phase proteins, and on the basis of the patterns of reaction 
obtained in the comparative analyses it was concluded that the antigenic 
determinants of each of the three acute phase protein antigens were situated 
on the same molecule a nd unable to diffuse independently. These conclu­
sions w ere confirmed by analysis of the corresponding antisera with the 
comparative interference diffusion-in-gel technique (II). 
Methodological aspects 
Comparative interference diffusion-in-gel analysis (II) 
The comparative interference diffusion-in-gel technique was elaborated 
in order to facilitate comparison of different antisera by means of a multi-
determinant antigen *). When such an antigen is analysed in the regular 
diffusion-in-gel technique with an antiserum containing antibodies against 
*) antigen particles carrying determinants of different specificity 
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1 
3 
(abc)A 
(abc)C 'C b C; C 
2 
4 
F i g .  2 .  Postulated (1) and obtained (2) reactions when goat anti-rabbit CxRP ( C D )  and 
goat anti-human CRP absorbed with CxRP (AB) were compared by means of human 
CRP (abc). The different patterns obtained with the comparative interference diffusion-
-in-gel technique with monkey CRP (bee) (3) and CxRP (cd) (4) in the circular 
basins demonstrate the different antibody contents of the compared antisera. Under­
lined antibodies are leading in the diffusion. 
two or more of these determinants, the initial composition of the precipita­
tion line depends on which of the antibodies is leading at the diffusion. 
This depends mainly on the concentration of the different antibodies but 
might also be due to differences of e.g. molec ular weight. Ouchterlony (78) 
in 1960 postulated that a reaction of mutual inhibition (one of his type 
IV reactions) should occur when two antisera with different leading anti­
bodies ar e compared by means of a multideterminant antigen with deter­
minants specific for each of the antibodies (Fig. 2:1). This reaction pattern 
could not be experimentally verified with the various homologous and 
heterologous acute phase protein — anti-acute phase protein systems studied, 
instead a reaction of fusion (reaction type I) was always obtained (Fig. 
2:2). These results we re in accord with those obtained by Korngold & van 
Leewwen (52) and Jennings (46, 47). The results obtained in I and II, 
contradictory to Ouchterlony's postulation, initiated further work to con­
firm the presumed character of the antibodies contained in the antisera 
employed for the analyses. To elucidate some of the factors involved, the 
comparative interference diffusion-in-gel technique was elaborated. In this 
technique an additional circular basin is estab lished in the expected area 
of interference of the regular comparative technique (Fig. 2:3 and 2:4). 
The reagents in the regular basins a re allowed to diffuse for 5—7 h when 
16 
Fig. 3. The six characteristic interference reaction patterns obtained with the com­
parative interference diffusion-in-gel technique. Antigen determinants are designated 
with lower-case letters, antibodies with upper-case letters, p, P and q, Q are hypo­
thesized constituents revealed by the test system, x, y and 2 are hypothesized con­
stituents not revealed by the test system. 
the precipitates begin to become visible. Then a suitable antigen mixed 
with agar is poured into the circular additional basin and the influence 
of this diffusing antigen on the developing precipitation lines can be 
studied. Thus the antigen-agar mix in this additional basin functions as a 
reactant reservoir as well as an area of reaction. Incorporation in the cir­
cular basin of an antigen with an antigen determinant reacting with the 
leading reacting antibody in the test antiserum, would interfere with the 
regular extension of the precipitation line causing a deviation or inhibi­
tion (Fig. 2:3 and 2:4, left). On the other hand an antigen without deter­
minants reacting with the pertinent antibody would not influence the for­
mation of the precipitation line (Fig. 2:4, right). 
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Fig. 4. Comparative interference analyses of CRPA absorbed with CxRP (upper outer 
basins) a nd anti-CxRP (central basin) by means of human CRP (lower basins and left 
circular basin) and monkey CRP (right circular basin). 
As test reactants were used the native acute phase protein antigens from 
man, monkey and rabbit and homologous and heterologous antisera to 
these. Both unabsorbed antisera and antisera absorbed with the two heterol­
ogous acute phase protein antigens were used. In total nine antisera with 
different contents of antibodies to various acute phase protein determi­
nants were employed. A careful check of the appropriate absorption of 
these antisera was performed with the diffusion-in-gel technique. By 
means of these tentatively designated reactants precipitation lines w ith an 
assumed initial composition could be established. (II, Table II). When 
the influence of the three acute phase protein antigens (in the circular 
basins) on precipitation lines which had been formed by different anti­
bodies was studied, six characteristic interference reaction patterns were 
obtained (Fig. 3). These patterns were in complete agreement with those 
postulated on the basis of the presumed antigen mosaics and antibody 
contents of the reactants used. A photograph of a representative compara­
tive interference diffusion-in-gel plate comprises Fig. 4. 
Thus it was concluded that the regular comparative technique is of 
limited differentiating value when different antisera are compared by 
means of a multideterminant antigen. With the comparative interference 
diffusion-in-gel technique, it is possible to differentiate antisera with re­
gard to the specificities of co ntained an tibodies. 
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CRP re f  
CRP re f  
•  CR PA 
Fig. 5- Comparative double diffusion-in-gel analysis (7-basin arrangement) for de­
monstration of CRP in four blood sera (SI — S 4) by means of CRPA (center basin) 
and a CRP reference antigen (upper and lower hatched basins). 
The type patterns described by Ouchterlony in 1960 for comparative 
analysis of antisera have since been accordingly revised (80, Fig. 19.16) 
on the basis of the present results ( II). 
Comparative double diffusion-in-gel analysis (III) 
For demonstration of CRP in blood sera the microplate technique of 
Wadsworth (105) was used. A seven-basin arrangement was employed 
with the central basin filled with antiserum (CRPA), two opposed basins 
with a CRP-containing reference antigen and the four remaining basins 
with the samples to be analysed (Fig. 5). With this arrangement two par­
allel reference CRP—CRPA precipitation lines are obtained. A very low 
CRP concentration in the sample analysed is sufficient to cause a dis­
cernible deviation of the reference precipitation line. By testing dilutions 
of a serum sample with known CRP concentration the sensitivity of the 
technique was estimated at about 0.5 fig/ml. This arrangement of basins 
and reactants is more easily interpreted than the five-basin arrangement 
used ea rlier (34, 74) (Fig. 6). A definite advantage of the diffusion-in-gel 
technique is the control of the immunological specificity of the precipi­
tates obtained and furthermore zonal effects occurring in some techniques 
(68, 69, 95) are eliminated. In addition, any adverse effects of hemolysis 
in the serum sample are minimized by diffusion-in-gel techniques. 
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Fig.  6.  Comparative double diffusion-in-gel analysis (5-basin arrangement) for de­
monstration of CRP in two blood sera (upper outer basins) by means of CRPA (lower 
basins) and a CRP reference a ntigen (upper central basin). 
Capillary tube precipitation technique (III) 
The technique was performed as described by Anderson & McCarty 
(6) with the following modification. In one of the series analysed (III, 
group A) the incubation period at 4°C was extended from 24 h to 48 h. 
This increased the sensitivity of the technique mainly by converting some 
of the negative results to trace reactions. 
Since preliminary investigations had shown that most of the sera con­
tained only low- concentrations of CRP an attempt to further increase the 
sensitivity of the technique was made by using the employed commercial 
antiserum diluted 1:4. In total, CRP was demonstrated in 25% of the 
sera from 50-year-old men when the employed antiserum was used un­
diluted. When the same antiserum was used diluted 1:4, CRP was shown 
in 42% of the sera. The dilution of the antiserum provides more optimal 
conditions for the precipitation reaction to occur at low CRP concentra­
tions (III). This is in accord with the considerations of Nakamura, Mag-
saysay, Ford & Kunitake (69). 
Halo technique (single radial diffusion) (III) 
The halo technique as described by Mancini et al. (64) is a s imple, accu­
rate and sensitive technique for immunochemical quantification of e.g. 
serum proteins. In this technique the antigen is allowed to diffuse from a 
circular basin punched out in an antiserum-containing agar gel. During 
diffusion circular antigen-antibody precipitates are formed in the im­
mune serum-agar mix. These continue to grow until balance between 
the reacting components is attained. The area of the precipitate is pro-
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portional to the antigen concentration which can be determined from 
comparison with simultaneously analysed reference antigens of known 
antigen concentrations. 
The use of the halo technique for quantification requires a certain 
knowledge of the antigen to be tested. T hus the antigenic properties must 
have been established especially in regard to its possible occ urrence as sev­
eral antigenic components. The immunological homogeneity of CRP as 
revealed by diffusion-in-gel analysis was shown in I and IT. 
Quantitative immunochemical techniques require either highly purified 
antigens or antisera which are specific agains t t he antigen to be measured. 
The last alternative is the most practical and usually employed. How­
ever, for standardization of the technique, at least if absolute and not only 
relative values of the antigen concentrations are desired, a highly purified 
antigen preparation is also required. A simple procedure for preparation 
of immunologically pure CRP has been described (III). It is important 
that the purified reference antigen has the same diffusion properties as 
the corresponding "native" antigens and that these do not vary among 
themselves when present in different sera. Thus, Fahey and McKelvey (18) 
found that about twice as much of a 9S IgA preparation as compared 
with a 7S IgA preparation was necessary to give the same area when 
tested with the halo technique. The studies of Hokama, Coleman & Riley 
(41) indicated that the CRP present in sera from different individuals 
interacted with the agar to various degrees. Although the findings ob­
tained in the present studies do not contradict an interaction with the 
agar the variability of this interaction of CRP from different individuals 
was not confirmed. On the contrary the diffusion constants for CRP in 
different sera as w ell as i n the reference antigen preparation varied only 
within the limits of experimental error when carefully balanced systems 
were analysed (III). Nor did the results of gel filtration of ten CRP-
containing sera indicate any differences in molecular weight since the 
CRP always appeared in the effluent at the same elution volume. It was 
concluded that from this point of view, under the experimental conditions 
used, t he halo technique would be suitable for quantification of CRP. 
In the original report of Mancini, Vaermant Carbonara & Heremans 
(65), the halo plates were incubated for 14 days and this time was also 
used in the present investigation to ascertain that balance was attained. 
For routine work this is a very long time and subsequent experience show­
ed it to be unnecessarily long. With adjustment of the antiserum con­
centration the diffusion time can be as short as 24 h even at relatively 
high CRP concentrations (73), and this time is u sually sufficiently short 
for clinical d emands. It should be mentioned that an increase of the anti­
serum concentration leads to a decreased se nsitivity of the technique (64). 
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The calculated error of the halo technique expressed as the coefficient 
of variation ranged between 3.4 and 5.1% for the CRP concentrations 
tested and is thus slightly larger than the corresponding figure, 2%, ob­
tained by Mancini et al. (64). This error is however still acceptable from 
a practical point of view. 
The sensitivity of the halo technique was estimated at approximately 
1 ug CRP/ml by testing dilutions of a CRP-containing serum with known 
CRP concentrations. This is in accord with the corresponding figures for 
the albumin — anti-albumin system studied by Mancini et al. (64). 
Comparison of immunoprecipitation methods for 
demonstration of CRP (III) 
In the literature the following methods have been employed for demon­
stration of CRP: 
1. Reaction with pneumococcal C-polysaccharide 
a) Precipitation (100) 
b) Skin test (4, 21) 
c) Hemagglutination (22) 
2. Nonspecific capsular swelling (59) 
3. Reaction with specific antiserum (CRPA) 
a) Precipitation in capillary tubes (6) 
b) Complement fixation (68, 85) 
c) Agglutination of antiserum-coated latex particles (95) 
d) Immunodiffusion methods (57, 92) 
e) Fluorescent antibody technique (26) 
4. Reaction with certain surface active substances (APC-test) (102) 
This study concerns only precipitation in capillary tubes and some im­
munodiffusion methods. 
The main drawback of precipitation with pneumococcal C-polysaccha-
ride is the laborious preparation of the substance. The introduction by 
Anderson & McCarty (6) of the CRPA precipitation test performed in 
capillary tubes was an important step forward and furthermore this 
method was shown to be at least ten times as sensitive as precipitation 
with C-polysaccharide (109). The precipitation reaction with C-poly­
saccharide was found not to be consistently positive at CRP concentra­
tions below 0.1 mg/ml whereas the precipitation reaction with CRPA 
would detect the presence of less t han 0.01 mg/ml (109). The nonspecific 
capsular swelling method of Löfström (59) was shown by Hedlund (35) 
to have approximately the same sensitivity as th e capillary tube precipita-
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Fig. 7. Relation between CRP concentration determined by the halo technique and by 
the capillary tube precipitation test in 135 CRP-containing sera. 
tion technique. Löfström's technique, however, although having interesting 
theoretical implications, has not been widely used mainly because of diffi­
culties in standardization of the readings. 
Nilsson & Hanson (74) pointed out the greater sensitivity of the 
CRPA precipitation technique when performed in a micromodification 
(105) of Ouchterlony's diffusion-in-gel technique (77). In these studies 
about 50% of sera obtained from blood donors and hospitalized patients 
were shown to contain CRP, although no CRP was demonstrated with 
the capillary tube technique. These analyses were extended and the greater 
sensitivity of the comparative double diffusion-in-gel technique was con­
firmed in the study on sera obtained from randomly selected 50-year-old 
men (III, group A). In this s tudy a different basin arrangement was used 
(Fig. 5) by means of which CRP could be demonstrated in about 80% of 
the sera reacting negatively in the capillary tube precipitation technique. 
Besides its higher sensitivity, the comparative double diffusion-in-gel 
technique provides a control of the specificity of the reaction. According 
to the results obtained with this technique the capillary tube technique 
gave false positive reactions in about 1% of the analysed sera. 
A comparison of the capillary tube precipitation technique and the 
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immunodiffusion techniques (comparative double diffusion and halo tech­
niques) for quantification of CRP in serum was also made. CRP was 
estimated in 135 serum samples from patients with these techniques (III, 
group B). It was shown that the distribution of CRP values obtained 
with the halo technique was very great within each CRP level as deter­
mined with the capillary tube technique (Fig. 7). Only at traces and 9 
mm of precipitate was the maximum CRP concentration (halo technique) 
less than twice the minimum concentration, and at some levels (1 and 
6 mm) the maximum CRP concentration exceeded the minimum concen­
tration by more than five times. I t was concluded that the halo technique 
is better suited than the capillary tube technique for quantification of 
CRP due to its greater specificity, sensitivity and accuracy. Furthermore 
the amount of antiserum required is very low. 
The limit of sensitivity of the capillary tube precipitation technique, 
reported to be about 10 [ig C RP/ml (109) is confirmed by the findings 
obtained in the present study (III, Table 5). 
Population studies (IV,V) 
According to the literature CRP is a protein not normally demonstrable 
in serum. Its appearance is elicited by various stimuli, the common de­
nominator of which seems t o be the induction of an inflammatory reac­
tion or tissue necrosis. Ava ilable evidence points to CRP as a very sensi­
tive indication of inflammatory disease or tissue necrosis and that changes 
of the CRP level reflect the course of the disease (15, 22, 48, 50, 53, 
59, 109, 110). 
Knights, Hutchins, Morgan & Ploompuu (49) demonstrated the pre­
sence of CRP in 12 % of a large series of blo od donors, but, on the basis of 
available data assumed that a positive reaction was indicative of a patho­
logical state existing in the donor. Preliminary studies performed by 
Nilsson (72) revealed an increasing prevalence rate of CRP-containing 
sera with increasing age. 
In the present analyses sera obtained from a series of randomly selected 
50-year-old men (IV) and a series of blood donors of different ages (V) 
were tested for the presence of CRP with qualitative and quantitative 
immunodiffusion techniques. 
In the analysis of sera from 50-year-old men the presence of CRP 
was demonstrated in 84°/o with the comparative double diffusion-in-gel 
technique. This prevalence rate was considered high since there was a 
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rather low incidence of clinically apparent disease in the series investi­
gated and the majority of the men were at active work (99). With the 
capillary tube precipitation test CRP could be demonstrated in only 25% 
of these men. Most of the positive reactions (21% of the total series) 
were trace reactions ( precipitate 1 mm). The discrepancy between the 
results obtained by the capillary tube precipitation technique and the 
diffusion-in-gel technique was ascribed to the higher sensitivity of the 
latter (III). The difference in sensitivity level, between the immuno­
diffusion techniques used in the present study and the techniques used 
for demonstration of CRP by other authors, would explain why they 
generally have not demonstrated CRP in subjects without apparent dis­
ease. For this reason it was considered worthwhile to ascertain at which 
CRP concentration a relationship to pathological conditions could be 
noted. 
Elevation of the erythrocyte sedimentation rate is another nonspecific 
indication of a pathological process in the organism. Since there is a well-
documented parallelism between prevalence of CRP and sedimentation 
rate (6, 48, 59, 87, 88, 104, 110), the latter variable was chosen to be 
compared with the CRP concentration. In addition, symptoms from the 
respiratory tract indicative of bronchitis at different stages as well as 
smoking habits were compared with the CRP concentration; because 
of the covariation of these variables (17, 107) it was expected that they 
would show similar relations to CRP concentration. It was found that 
the prevalence rates of sera with CRP concentrations equal to or higher 
than 1—4.2 |.ig/ml increased with increasing sedimentati on rate, increasing 
cigarette consumption, as well as increasing severity of respiratory symp­
toms. On the other hand the prevalence rates of sera containing trace 
amounts of CRP as well as the negatively reacting sera decreased when 
these variables increased. On the basis of these findings it was therefore 
suggested that the presence of trace amounts (<C 1 [xg/ml) of CRP is of 
minor clinical significance if incipient or declining disease can be excluded. 
Studies performed on sera from 98 healthy children (89) revealed a 
much lower incidence of CRP-containing sera (17%) than found in the 
present st udy on sera from 50-year-old men (84%) (IV). For this reason 
it was thought worthwhile to examine the prevalence rates of sera with 
different CRP concentrations and their relation to the age of apparently 
healthy individuals (V). A series of 'blood donors was considered suitable 
since t here are uniform health demands for the admittance to donation 
of blood. The similarity in state of health within the different age groups 
was indicated by the even distribution of the very few high sedimentation 
rates Ç> 15 mm/h) recorded, as well as similar prevalence rates f or CRP 
concentrations exceeding 4.2 flgfml. Values exceeding this level could 
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Fig.  8.  Prevalence rates of sera with different CRP concentrations related to age in a 
series of 405 blood donors. 
probably be considered as an expression of morbidity (IV). On the other 
hand the prevalence rates of sera without demonstrable CRP decreased 
significantly from 49% in the age group 18—24 years to 23 °/o in the 
age group 45—49 years (Fig. 8). There was an increase in prevalence 
rates of sera with trace amounts of CRP and, although to a lesser degree, 
in prevalence rates of sera with CRP concentrations between 1 and 4.2 
^tg/ml w ith increasing age. Since the presence of trace amounts (<C 1 |xg 
CRP/ml) could not be shown to be related to clinically demonstrable 
diseases (IV) it was suggested that the presence of trace amounts and 
possibly in some instances concentrations up to about 4 ^ig/ml is ind icative 
of changes associated with aging. 
Consideration of the implications of these results raised the question 
of the normal limit for blood serum CRP. It was proposed that CRP 
might occur in low concentrations in normal subjects, that is, i n subjects 
without clinically demonstrable disease. To evaluate a positive finding 
within the low range in a single specimen as an indication of incipient or 
declining disease or "normal", a follow-up testing of the individual is 
necessary. Further studies on clinical series a nd long-term follow-up stu­
dies of healthy subjects should elucidate this question. 
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Summary 
1. The antigen mosaics of acute phase proteins from man, monkey and 
rabbit were studied by means of the comparative double diffusion-in-
gel technique. The results obtained indicated the presence of at least 
five antigenic determinants in the three different acute phase pro­
teins. One factor (c) is common to all three species, another (b) is 
found in man and monkey but not in rabbit, while three others are 
probably specific for man (a), monkey (e) and rabbit (d). In each 
type of acute phase protein the pertinent antigenic determinants are 
situated on the same molecule and unable to diffuse independently. 
No indications of an immunological heterogeneity of the proteins 
were obtained, whereas immunoelectrophoretic studies indicated an 
electrophoretic heterogeneity. In order to confirm the multispecificity 
of the acute phase proteins an immunotechnique, a comparative inter­
ference diffusion-in-gel technique, was elaborated. This method is 
particularly useful for characterization of the antibody content of 
antisera to multispecific antigens. 
2. The capillary tube precipitation technique, the double diffusion-in-gel 
technique and the halo (single radial diffusion) technique were em­
ployed for estimation of C-reactive protein and the results obtained 
with these techniques were compared. The greater sensitivity, speci­
ficity and accuracy of the immunodiffusion techniques as compared to 
the capillary tube precipitation technique was demonstrated. It was 
concluded that the halo technique is well suited for routine quanti­
fication of C-reactive protein. 
3. Sera obtained from a series of 50-year-old men and a series of blood 
donors of different ages were tested for the presence of CRP by means 
of the aforementioned immunodiffusion techniques. It was found that 
C-reaçtive protein may be present in low concentrations (trace amounts 
and possibly up to about 4 jig/ml) in sera from apparently healthy 
individuals. The prevalence rate of sera with low CRP concentrations 
increased with increasing age. 
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